Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Lung cancer, Small cell lung cancer
Closed
Phase 3
This trial is looking at whether giving immunotherapy can delay or prevent small cell lung cancer (SCLC) coming back after first treatment. It is for people with SCLC that has spread to another part of the body.
Recruitment start: 13 October 2015
Recruitment end: 8 September 2017
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Martin David Forster
Bristol-Myers Squibb
Last reviewed: 12 September 2017
CRUK internal database number: 13771